Close Menu

People in the News

May 06, 2020

OraSure Technologies: Lisa Nibauer

OraSure Technologies has appointed Lisa Nibauer as executive vice president and business unit leader for infectious disease. She will replace Tony Zezzo, who has announced that he will retire from the company. Zezzo's official retirement date will be mutually determined, and he will maintain his current role in OraSure's COVID-19 activities while he coordinates the transition with Nibauer, who will join the company on May 11. Nibauer most recently served as vice president and general manager of global medication delivery solutions at Becton Dickinson.

May 06, 2020

First Light Diagnostics: Joanne Spadoro

First Light Diagnostics announced that Joanne Spadoro is the company's COO. Last September she joined the company as VP of R&D and regulatory affairs. Previously, Spadoro was senior VP of product development and operations at Roche Molecular Systems, leading the teams that launched PCR-based products globally for infectious disease diagnostics, viral load monitoring, and blood screening applications. 

She also served as CSO and worldwide VP of operations at Immucor, developing the company's molecular immunohematology test for the detection of extended blood antigens. Spadoro was also previously the COO at T2 Biosystems. 

May 05, 2020

Grail: Mostafa Ronaghi

Mostafa Ronaghi has joined Grail's board of directors. Ronaghi is currently Illumina's senior vice president of entrepreneurial development, and previously served as the company's senior VP and chief technology officer, a role in which he led internal research and technology and cofounded Grail. He also cofounded the Illumina Accelerator.

In 2007, Ronaghi cofounded Avantome, a privately held sequencing company that was acquired by Illumina in 2008. Before this, he cofounded NextBio, a search engine for life science data that was acquired by Illumina in 2013. In 2001, Ronaghi cofounded ParAllele Bioscience, which was eventually acquired by Affymetrix, and was involved in the development and commercialization of highly multiplexed technology for genetic testing. In 1997 he cofounded Pyrosequencing AB, which was renamed Biotage in 2003. Ronaghi earned his PhD from the Royal Institute of Technology in Sweden and was a principal investigator at Stanford University from 2002 until 2008, focused on the development of novel tools for molecular diagnostic applications. He also serves on the board of directors of BaseHealth and Clear Labs. 

May 04, 2020

Oncimmune: Richard Sharp

Oncimmune Holdings announced Richard Sharp has stepped down as a non-executive director of the firm, effective May 4, in order to focus on his new role as senior strategic adviser to the UK government in connection with the coronavirus pandemic. Sharp remains a shareholder in Oncimmune.

Pages